🔗 Share this article

The top legal official in Texas Paxton is taking legal action against the producers of Tylenol, claiming the companies withheld alleged dangers that the drug presented to children's neurological development.

The court filing comes four weeks after President Donald Trump promoted an unsubstantiated connection between using Tylenol - also known as acetaminophen - during pregnancy and autism in children.

The attorney general is taking legal action against J&J, which formerly manufactured the drug, the exclusive pain medication approved for women during pregnancy, and the current manufacturer, which currently produces it.

In a statement, he stated they "misled consumers by gaining financially from discomfort and promoting medication regardless of the risks."

The manufacturer says there is lacking scientific proof tying Tylenol to autism spectrum disorder.

"These corporations deceived for years, intentionally threatening numerous people to line their pockets," the attorney general, from the Republican party, stated.

The manufacturer commented that it was "very worried by the perpetuation of misinformation on the security of paracetamol and the potential impact that could have on the welfare of women and children in America."

On its online platform, Kenvue also stated it had "regularly reviewed the pertinent research and there is no credible data that demonstrates a verified association between taking acetaminophen and autism."

Associations speaking for doctors and health professionals concur.

ACOG has declared paracetamol - the main ingredient in acetaminophen - is a restricted selection for women during pregnancy to treat discomfort and fever, which can create serious health risks if left untreated.

"In more than two decades of investigation on the utilization of acetaminophen in gestation, not a single reputable study has definitively established that the consumption of acetaminophen in any stage of gestation results in neurodevelopmental disorders in young ones," the association said.

The court filing cites current declarations from the Trump administration in claiming the medication is potentially dangerous.

Last month, the former president generated worry from public health officials when he instructed pregnant women to "resist strongly" not to use acetaminophen when unwell.

The US Food and Drug Administration then released a statement that physicians should contemplate reducing the consumption of Tylenol, while also declaring that "a direct connection" between the drug and autism spectrum disorder in children has not been proven.

The Health Department head Kennedy, who supervises the FDA, had vowed in April to conduct "a massive testing and research effort" that would determine the cause of autism spectrum disorder in a limited time.

But specialists cautioned that finding a single cause of autism - thought by researchers to be the consequence of a complex mix of inherited and surrounding conditions - would be difficult.

Autism spectrum disorder is a category of permanent neurological difference and disability that influences how persons perceive and interact with the environment, and is diagnosed using physician assessments.

In his court filing, Paxton - a Trump ally who is campaigning for the Senate - alleges Kenvue and J&J "intentionally overlooked and attempted to silence the research" around acetaminophen and autism spectrum disorder.

The lawsuit seeks to make the corporations "eliminate any commercial messaging" that asserts acetaminophen is safe for expectant mothers.

This legal action parallels the grievances of a group of guardians of children with autism spectrum disorder and attention deficit hyperactivity disorder who filed suit against the manufacturers of acetaminophen in two years ago.

A federal judge threw out the lawsuit, saying investigations from the family's specialists was not conclusive.